1. Home
  2. SUIG vs VYGR Comparison

SUIG vs VYGR Comparison

Compare SUIG & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sui Group Holdings Limited

SUIG

Sui Group Holdings Limited

N/A

Current Price

$1.21

Market Cap

270.0M

Sector

Finance

ML Signal

N/A

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.39

Market Cap

222.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUIG
VYGR
Founded
2006
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
270.0M
222.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SUIG
VYGR
Price
$1.21
$3.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$5.75
$17.00
AVG Volume (30 Days)
748.1K
631.7K
Earning Date
03-09-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,608,807.00
$31,316,000.00
Revenue This Year
$47.71
N/A
Revenue Next Year
$42.04
$71.77
P/E Ratio
N/A
N/A
Revenue Growth
11.58
N/A
52 Week Low
$1.13
$2.65
52 Week High
$8.66
$5.55

Technical Indicators

Market Signals
Indicator
SUIG
VYGR
Relative Strength Index (RSI) 29.52 36.03
Support Level $1.17 $3.36
Resistance Level $1.33 $3.91
Average True Range (ATR) 0.13 0.22
MACD -0.02 -0.04
Stochastic Oscillator 10.00 12.58

Price Performance

Historical Comparison
SUIG
VYGR

About SUIG Sui Group Holdings Limited

Sui Group Holdings Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: